# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018927
Filing Date
2023-05-08
Accepted
2023-05-08 17:29:46
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-20230331.htm iXBRL | 10-Q | 2164679
2 | EX-31.1 | acad-ex31_1.htm | EX-31 | 13453
3 | EX-31.2 | acad-ex31_2.htm | EX-31 | 13708
4 | EX-32.1 | acad-ex32_1.htm | EX-32 | 9846
5 | EX-32.2 | acad-ex32_2.htm | EX-32 | 9904
| Complete submission text file | 0000950170-23-018927.txt |  | 8057782

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | acad-20230331_pre.xml | EX-101.PRE | 259245
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | acad-20230331_def.xml | EX-101.DEF | 121230
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | acad-20230331.xsd | EX-101.SCH | 44355
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | acad-20230331_cal.xml | EX-101.CAL | 52305
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | acad-20230331_lab.xml | EX-101.LAB | 352502
55 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20230331_htm.xml | XML | 1719819

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 23899096
SIC: 2834 Pharmaceutical Preparations